Wildcat Capital Management, LLC
CIK
1582384
Location
New York, NY
Portfolio Value
Small
$106,183,289
Diversification
Highly concentrated
Filing Date
Global Rank
#5,232
/ 8,232
▼ 258
Top Industry
Airlines
93.3%
3Y Alpha vs SPY
+11.4%
Period ended 2 months ago
Filed May 1, 2026 · 44d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+131.1%
SPY
+76.3%
Annualised alpha
+11.4%
Max drawdown
−61.2%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
2 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
93.3%
−3.6 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
8,748
Highly concentrated−643
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Industrials | 93.3% | $99,056,569 |
| Healthcare | 6.7% | $7,126,720 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| PCOR | Procore Technologies, Inc. | 3,851 | $280,121 | |
| No positions match the current search. | ||||
2 positions ·
$106,183,289 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ULCC |
Frontier Group Holdings, Inc.
Industrials
|
Held | 28,061,351 | $99,056,569 | 93.29% | |
| ALLO |
Allogene Therapeutics, Inc.
Healthcare
|
Held | 2,920,787 | $7,126,720 | 6.71% |